LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

Search

Medtronic PLC

Open

BrancheGesundheitswesen

92.06 0.11

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

91.35

Max

92.11

Schlüsselkennzahlen

By Trading Economics

Einkommen

-17M

1B

Verkäufe

-349M

8.6B

KGV

Branchendurchschnitt

25.425

35.724

EPS

1.26

Dividendenrendite

3.03

Gewinnspanne

12.124

Angestellte

95,000

EBITDA

-50M

2.2B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+7.51% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

3.03%

3.09%

Nächstes Ergebnis

18. Nov. 2025

Nächste Dividendenausschüttung

17. Okt. 2025

Nächstes Ex-Dividendendatum

26. Sept. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-987M

118B

Vorheriger Eröffnungskurs

91.95

Vorheriger Schlusskurs

92.06

Nachrichtenstimmung

By Acuity

49%

51%

170 / 372 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Medtronic PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Aug. 2025, 11:39 UTC

Ergebnisse

Medtronic Posts Higher 1Q Revenue, Boosts Outlook as Tariffs Ease

21. Mai 2025, 11:38 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Medtronic Boosts Dividend, Plans to Separate Diabetes Business and Targets Revenue Growth for Year

19. Aug. 2025, 20:33 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

These Stocks Moved the Most Today: Intel, Home Depot, Palo Alto, Viking Therapeutics, Palantir, Medtronic, and More -- Barrons.com

19. Aug. 2025, 17:41 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19. Aug. 2025, 13:35 UTC

Heiße Aktien

Stocks to Watch Tuesday: Intel, Medtronic, Home Depot -- WSJ

19. Aug. 2025, 12:48 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19. Aug. 2025, 11:27 UTC

Ergebnisse

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. -- Barrons.com

19. Aug. 2025, 10:51 UTC

Ergebnisse

Medtronic Sees FY26 Reported Revenue Growth 6.5%-6.8% >MDT

19. Aug. 2025, 10:50 UTC

Ergebnisse

Medtronic Had Seen FY26 Adjusted EPS $5.50-$5.60 >MDT

19. Aug. 2025, 10:50 UTC

Ergebnisse

Medtronic Raises FY26 View To Adj EPS $5.60-Adj EPS $5.66 >MDT

19. Aug. 2025, 10:50 UTC

Ergebnisse

Medtronic Cuts FY26 Potential Tariff Impact View to About $185M From $200M-$350M >MDT

19. Aug. 2025, 10:49 UTC

Ergebnisse

Medtronic Raises FY26 Adjusted EPS Growth View to About 4.5% From About 4%, Excluding Potential Tariff Impact >MDT

19. Aug. 2025, 10:48 UTC

Ergebnisse

Medtronic Still Sees FY26 Organic Revenue Up About 5% >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Medical Surgical Portfolio Rev $2.08B >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Cardiovascular Portfolio Rev $3.29B >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Neuroscience Portfolio Rev $2.42B >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Organic Revenue Up 4.8% >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q EPS 81c >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Net $1.04B >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Diabetes Rev $721M >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Sales $8.58B >MDT

19. Aug. 2025, 10:45 UTC

Ergebnisse

Medtronic 1Q Adj EPS $1.26 >MDT

19. Aug. 2025, 09:12 UTC

Heiße Aktien

Stocks to Watch Tuesday: Intel, Palo Alto, Tegna, Home Depot -- WSJ

12. Juni 2025, 13:01 UTC

Akquisitionen, Fusionen, Übernahmen

Medtronic Targeting Completion of Planned Separation Within 18 Mos of Initial Announcement >MDT

21. Mai 2025, 17:23 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Medtronic to Separate Diabetes Business as Stand-Alone Company -- 2nd Update

21. Mai 2025, 11:39 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Medtronic to Separate Diabetes Business as Stand-Alone Company -- Update

21. Mai 2025, 10:52 UTC

Ergebnisse

Medtronic Sees FY26 Adjusted EPS Up About 4% Excluding Potential Impacts From Increased Tariffs >MDT

21. Mai 2025, 10:51 UTC

Ergebnisse

Medtronic Sees FY26 Adj EPS $5.50-Adj EPS $5.60, Including Potential Tariff Impact >MDT

21. Mai 2025, 10:50 UTC

Ergebnisse

Medtronic Sees FY26 Reported Revenue Up 4.8%-5.1% if Recent Forex Rates Hold >MDT

21. Mai 2025, 10:49 UTC

Ergebnisse

Medtronic Sees FY26 Organic Revenue Growth Up About 5% >MDT

Peer-Vergleich

Kursveränderung

Medtronic PLC Prognose

Kursziel

By TipRanks

7.51% Vorteil

12-Monats-Prognose

Durchschnitt 99.1 USD  7.51%

Hoch 115 USD

Tief 78 USD

Basierend auf 26 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Medtronic PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

26 ratings

12

Buy

13

Halten

1

Sell

Technischer Score

By Trading Central

83.26 / 84.875Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

170 / 372 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.